1型糖尿病中胰岛素抵抗与心血管疾病及全因死亡的关联:系统综述与Meta分析
该系统综述与Meta分析纳入8项观察性研究共21930例1型糖尿病患者,评估由估算葡萄糖处置率(eGDR)计算的胰岛素抵抗与心血管疾病及全因死亡的关联。eGDR指数每增加1单位,复合心血管结局的汇总风险比为0.83(95%CI 0.78-0.90,I²=58.9%),全因死亡的汇总风险比为0.84(95%CI 0.81-0.87,I²=0%)。作者认为eGDR计算的胰岛素抵抗可能是1型糖尿病中心血管疾病和全因死亡的额外危险因素。
要点
- eGDR指数每增加1单位,复合心血管结局风险降低,汇总HR为0.83(95%CI 0.78-0.90)。
- eGDR指数每增加1单位,全因死亡风险降低,汇总HR为0.84(95%CI 0.81-0.87)。
- 作者认为eGDR计算的胰岛素抵抗可能是1型糖尿病中心血管疾病和全因死亡的额外危险因素。
核心结论
- 由eGDR计算的胰岛素抵抗可能是1型糖尿病中心血管疾病和全因死亡的额外危险因素。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Embase和Cochrane Library数据库自建库至2023年10月31日。
- 纳入报告由eGDR计算的胰岛素抵抗与1型糖尿病心血管疾病及全因死亡风险关联的观察性研究。
- 共纳入8项研究涉及21930例个体,其中5项研究涉及19960例1型糖尿病患者报告心血管疾病风险,5项研究涉及19403例个体报告全因死亡风险。
- 数据采用随机效应模型合并,结果以风险比(95%CI)表示。
主要发现
- 中位随访10年期间,发生2149例新发心血管疾病事件;eGDR指数每增加1单位,复合心血管结局的汇总HR为0.83(95%CI 0.78-0.90,I²=58.9%)。
- 中位随访10年期间,观察到1279例死亡;eGDR指数每增加1单位,全因死亡的汇总HR为0.84(95%CI 0.81-0.87,I²=0%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 可用的研究数量少,限制了我们进行Meta回归分析或更详细的亚组分析的能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The association of insulin resistance (IR) with cardiovascular disease (CVD) and all-cause mortality in type 1 diabetes (T1D) remains unclear. PURPOSE: To investigate whether IR is associated with CVD and all-cause mortality among individuals with T1D. DATA SOURCES: PubMed, Embase, and the Cochrane Library databases were searched from inception to 31 October 2023. STUDY SELECTION: Observational studies reporting the associations between IR, as calculated by the estimated glucose disposal rate (eGDR), and the risk of CVD and all-cause mortality in individuals with T1D were eligible for inclusion. DATA EXTRACTION: Data from eight selected studies were extracted, pooled by random-effects models, and results are presented as hazard ratios (95% CIs). DATA SYNTHESIS: Eight studies involving 21,930 individuals were included, of which five studies involving 19,960 individuals with T1D reported the risk of CVD. During a median follow-up of 10 years, there were 2,149 cases of incident CVD. The pooled hazard ratio for composite CVD outcome per 1-unit increase in the eGDR index was 0.83 (95% CI 0.78-0.90, I2 = 58.9%). Five studies involving 19,403 individuals reported the risk of all-cause mortality. During a median follow-up of 10 years, 1,279 deaths were observed. The pooled hazard ratio for all-cause mortality per 1-unit increase in the eGDR index was 0.84 (95% CI 0.81-0.87, I2 = 0%). LIMITATIONS: The small number of available studies restricted our ability to perform meta-regression analyses or more detailed subgroup analyses. CONCLUSIONS: IR, as calculated by the eGDR, may be an additional risk factor for CVD and all-cause mortality in T1D.
引用
- Sun R, Wang J, Li M, et al. Association of Insulin Resistance With Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: Systematic Review and Meta-analysis. Diabetes Care. 2024. PMID: 39018337. doi:10.2337/dc24-0475
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。